Introduction
============

With continuous increase in life expectancy due to the improvement in healthcare systems, the number of elderly population is expected to arise ([@b1-06mjms26032019_oa3], [@b2-06mjms26032019_oa3]). This situation comes with the debilitating effects of chronic pathologies as the population grows older. However, of all the changes which occur during the aging process, deterioration in mental health and cognitive is perhaps the single most disabling condition ([@b3-06mjms26032019_oa3]). It is also the most feared part of getting old. Some mental health issues, such as depression and insomnia are known to be common among the aging society ([@b4-06mjms26032019_oa3]). Some mental functions, i.e. verbal and numerical abilities and general knowledge seem robust to aging, however, certain capabilities like memory, executive functions, processing speed and reasoning showed deterioration as one ages ([@b5-06mjms26032019_oa3], [@b6-06mjms26032019_oa3]).

Many factors are found to be associated with poor mental health and cognitive status related to aging. This include the presence of chronic diseases, cigarette smoking and social, mental and physical inactivity. In contrast, dietary intake such as omega-3 fatty acids and vitamin B are found to be protective against the deterioration of mental health and cognitive status. Recently, a number of studies have strongly supported the role for polyphenols in the prevention of degenerative diseases, particularly neurodegenerative diseases including poor mental health and cognitive status ([@b7-06mjms26032019_oa3], [@b8-06mjms26032019_oa3]). Polyphenols are secondary metabolites of plants and are found naturally in fruits, vegetables, cereals, olive, dry legumes, chocolate and beverages, such as tea, coffee and wine ([@b9-06mjms26032019_oa3]). Increasing number of studies have described the roles of polyphenols, in particular flavonoids, in the prevention of human disease related to aging, such as cognitive impairment and Alzheimer's disease through their antioxidant properties ([@b10-06mjms26032019_oa3]). In a study by Krikorian et al., a total of eight men and four women, with mean age of 78 ± 5 years were supplemented with either Concord grape juice (Welsh's) or placebo for 6--9 mL/kg body weight divided over three servings for 12 weeks ([@b11-06mjms26032019_oa3]). The result showed that intake group had significantly better verbal memory acquisition as compared to placebo group at 12 weeks intervention period. No significant effect on delayed verbal memory and spatial memory were found. However, the studies are still scarce for conclusive evidence can be made. Moreover, these studies mainly aim the elderly groups although the signs and symptoms of poor mental health and cognitive status related to aging may start during the middle-age, and thus, early intervention can be started earlier. Therefore, this study aims to determine the prevalence of poor mental health and cognitive status among middle-aged adults and its predictors in relation to polyphenols intake.

Subjects and Methods
====================

This cross-sectional study involves a total of 339 middle-aged adults (aged 45--59 years), recruited from a low-cost housing flats in Kuala Lumpur. Sample size was calculated using a formula by ([@b12-06mjms26032019_oa3]), with the level of precision and confidence interval set at 5% and 95%, respectively. Additionally, the estimation of prevalence was 10% according to the prevalence of cognitive impairment in middle-aged adults reported in ([@b13-06mjms26032019_oa3]). From the calculation, the sample size was estimated to be 138.

Informed consent was obtained after providing written and verbal information to the subjects and subsequently, personal data and health profiles were collected from the subjects. Ethical approval was obtained from the Secretariat for Medical Research and Innovation, Universiti Kebangsaan Malaysia (NN-084-2013). Subjects were assessed for anthropometric, dietary intake, mental health and cognitive status.

Anthropometric Measurements
---------------------------

Anthropometric profiles of the subjects such as standing height, weight and waist and circumferences were taken twice by a trained nutritionist and later the mean value was recorded. The standing height and weight values were used to calculate the body mass index (BMI) ([@b14-06mjms26032019_oa3]). Additionally, the subjects were classified as having increased risk of metabolic risk if their waist-hip ratio were ≥ 0.90 and ≥ 0.85 for men and women, respectively ([@b15-06mjms26032019_oa3]).

Dietary Intake
--------------

The Malay version of dietary history questionnaire was used to assess the subjects' dietary intake ([@b16-06mjms26032019_oa3]). It included the type of food, quantity and time of food intake throughout the day. Subsequently, the amount of energy and nutrients intake by the subjects was calculated using NutritionistPro (Axxya Systems Stafford, USA).

The food frequency questionnaire (FFQ) for polyphenols was utilised to analyse the subjects' intakes of polyphenols. The intake of total polyphenols, phenolic acids, flavonoids, stillbenes and lignan was then calculated by referring to Phenol-explorer database.

Mental Health
-------------

The general health questionnaire-28 (GHQ-28) consisted of 28 questions and subscales of somatic symptoms, anxiety and insomnia, social dysfunction and severe depression ([@b17-06mjms26032019_oa3]). For this study, the Malay version of GHQ-28 was used to assess the mental health status of the subjects ([@b18-06mjms26032019_oa3]). A study was conducted among healthy adults in Malaysia indicated that the sensitivity and specificity of GHQ was 87.5% and 80.6%, respectively, when validated against Beck Depression Inventory. Additionally, positive predictive value and area under ROC curve was 70% and 0.84, respectively. Cronbach's alpha was 0.93, whilst Kappa coefficient was 0.64 ([@b18-06mjms26032019_oa3]). Any score exceeding the threshold of 4 was considered as having the risk of poor mental health status.

Cognitive Status
----------------

In order to assess the subjects' cognitive functions, the Malay version of Rey auditory verbal learning test (RAVLT) was used. It was proven useful in evaluating verbal learning and memory, including proactive inhibition, retroactive inhibition, retention, encoding versus retrieval, and subjective organisation ([@b19-06mjms26032019_oa3]).

The RAVLT consists of two different lists (A and B) of 15 concrete nouns. Subjects were asked to read list A five times (Recall 1 to Recall 5) at a rate of one item per second. Free verbal recall was tested immediately after each presentation. Then list B was presented followed by a free recall of list B. Thereafter, recall of list A (A6) was examined without prior presentation of list A. Subjects were classified as having poor cognitive status if their scores were lower than mean---1.5 standard deviation (SD) ([@b20-06mjms26032019_oa3]).

A study by Boone et al. ([@b21-06mjms26032019_oa3]) shows that the values of sensitivity and specificity of RAVLT were 73.8% and 90.0%, respectively, when validated against patients aged 16 to 64 years. In a study by Jamaluddin et al. ([@b22-06mjms26032019_oa3]), Malay version of RAVLT showed good validity (factor analysis 0.66 to 0.98) and test-retest reliability (Pearson's correlation ranged from 0.24 to 0.84). Additionally, a study by Baitil Husna ([@b23-06mjms26032019_oa3]) indicated that the Cronbach's alpha values for Malay version RAVLT was 0.74 and 0.84 for learning and memory sections, respectively.

Statistical Analysis
--------------------

All data were analysed using Statistical Package for Social Sciences (SPSS) version 21. Normality test Kolmogorov-Smirnov test was carried out before any statistical analysis. Socio-demography, social, health, anthropometric, biochemical, dietary and cognitive data was presented in mean and standard deviation. Categorical variables such as physical activity, living arrangements, years of education and smoking habit were presented as frequency and percentage. The association of nutrients and polyphenols with mental health and cognitive status was conducted using univariate Pearson's correlation. Subsequently, associations between categorical data and mental health and cognitive status were tested using chi-square (χ^2^) test. Binary logistic regression was carried out to determine the predictors of poor mental health and cognitive status for both men and women.

Results
=======

A total of 349 middle-aged adults participated in this study, with 34.7% (*n* = 121) men and 65.3% (*n* = 228) women. The mean age for the male and female subjects were 53.7 ± 3.8 and 52.0 ± 4.3 years, respectively. Most of the subjects were married, had education until secondary level, retired, living with family members and socially inactive ([Table 1](#t1-06mjms26032019_oa3){ref-type="table"}). Additionally, most subjects did not engage in regular physical activities, did not smoke and drink alcohol and had no intake of nutritional supplements ([Table 2](#t2-06mjms26032019_oa3){ref-type="table"}).

[Table 3](#t3-06mjms26032019_oa3){ref-type="table"} shows the energy and nutrients intakes by the subjects. Men (1933.3 ± 559.8 kcal) showed higher intakes of energy as compared to women (1586.3 ± 493.0 kcal) (*t* = 3.161; *P* \< 0.01). Higher macronutrients intakes such as protein (*t* = 3.061; *P* \< 0.01), fat (*t* = 2.857; *P* \<0.01), carbohydrates (*t* = 2.458; *P* \< 0.05) were also observed in men as compared to women.

With respect to micronutrient intake, men (1311.1 ± 778.6 mg) showed significantly higher intake of sodium as compared to women (966.8 ± 578.9 mg) (*t* = 2.522; *P* \< 0.05). Similarly, men (9.6 ± 3.0 mg) had higher niacin intake as compared to women (7.6 ± 3.0 mg) (*t* = 3.146; *P* \< 0.01).

As shown in [Figure 1](#f1-06mjms26032019_oa3){ref-type="fig"}, more men met the Reference Nutrient Intake (RNI) requirements for energy, protein, calcium, iron and vitamin C as compared to women. In contrast, women showed higher intakes for thiamine, riboflavin, niacin and vitamin E. None of the subjects met the RNI requirement for folate.

As shown in [Table 4](#t4-06mjms26032019_oa3){ref-type="table"}, the total polyphenols intake were 1131.8 ± 568.8 mg/day and 947.2 ± 549.5 mg/day for men and women, respectively. Phenolic acid was the highest individual polyphenols group consumed by the subjects, with intakes of 452.7 ± 444.3 mg/day and 357.5 ± 393.0 mg/day for men and women, respectively. There was no significant difference in the total and individual classes of polyphenols intake between men and women.

[Figures 2](#f2-06mjms26032019_oa3){ref-type="fig"}--[3](#f3-06mjms26032019_oa3){ref-type="fig"} show that most subjects were classified as overweight (about 45%) and had increased risk of metabolic complications (about 80%) according to waist-hip ratio, respectively.

[Figures 4](#f4-06mjms26032019_oa3){ref-type="fig"}[](#f5-06mjms26032019_oa3){ref-type="fig"}[](#f6-06mjms26032019_oa3){ref-type="fig"}[](#f7-06mjms26032019_oa3){ref-type="fig"}--[8](#f8-06mjms26032019_oa3){ref-type="fig"} show the prevalence of symptoms of poor mental health by gender disparities based on GHQ. About 26% of women were classified as having somatic symptoms as compared to men (14.9%). In addition, more than 17% of women had poor score in anxiety and insomnia category of GHQ as compared to men (10.7%). In contrast, social dysfunction was the only category with more men (4.1%) were found to have poor score as compared to women (0.9%). No men were found to show symptoms of severe depression as identified by GHQ, whereas 4.82% of women showed poor score in this category. Additionally, the total score of GHQ also showed that more women (47.81%) had poor score as compared to the male counterpart (31.4%).

[Figure 9](#f9-06mjms26032019_oa3){ref-type="fig"} shows the prevalence of subjects with poor score in both RAVLT categories according to gender. More men were found to have poor score in both categories as compared to women. For total immediate recall, about 69.4% and 67.1% of men and women, respectively, were found to have poor score. Similarly, a total of 52.1% and 50.9% of men and women, respectively, had poor score in delayed recall categories.

[Table 5](#t5-06mjms26032019_oa3){ref-type="table"} shows the association of nutrients and polyphenols intake with mental health and cognitive functions using univariate Pearson's correlation. There was a significant correlation between phenolic acids and anxiety and insomnia (*r* = 0.227, *P* \< 0.05), severe depression (*r* = 0.241, *P* \< 0.05) and total GHQ score (*r* = 0.225, *P* \< 0.05). In addition, there was a negative correlation between total flavonoids intake with somatic symptoms (*r* = −0.222, *P* \< 0.05), anxiety and insomnia (*r* = −0.190, *P* \< 0.05), total GHQ score (*r* = −0.231, *P* \< 0.05) and RAVLT immediate recall (*r* = −0.213, *P* \< 0.05). Other significant correlation include fat intake and somatic symptoms (*r* = 0.198, *P* \< 0.05), calcium and anxiety and insomnia (*r* = −0.027, *P* \< 0.05), iron and total GHQ score (*r* = −0.202, *P* \< 0.05), vitamin A and RAVLT delayed recall (*r* = −0.206, *P* \< 0.05), anthocyanins and total GHQ score (*r* = 0.344, *P* \< 0.05) and lignan and RAVLT immediate recall (*r* = 0.263, *P* \< 0.05).

[Table 6](#t6-06mjms26032019_oa3){ref-type="table"} and [Table 7](#t7-06mjms26032019_oa3){ref-type="table"} show the result of binary logistic regression analysis for the predictors of symptoms of poor mental health and cognitive in men and women, respectively, after controlling for education status, household income and energy intake. Analysis was not able to be carried out for social dysfunction and severe depression due to the low prevalence of both categories in this study. Demographic and health factors were analysed in Step 1 and Step 2, respectively. Step 3 was used to analyse dietary intakes, including polyphenols. The result shows that fat intake was found to be significantly associated somatic symptoms for both genders (*P* \< 0.05). In addition, for women, iron intake was associated with total GHQ score (*P* \< 0.05). For cognitive functions, lignan intake and high cholesterol were associated with RAVLT immediate and delayed recalls, respectively, among women (*P* \< 0.05).

Discussion
==========

The number of middle-aged adults successfully recruited in this study is more than the sample size required based on the prevalence of cognitive impairment in middle-aged adults reported in 13. Nunley et al. ([@b13-06mjms26032019_oa3]). This study involved various low-cost housing flats located around Kuala Lumpur, and subjects were recruited through advertisement in their community.

This study shows that the intake of total polyphenols in the current study (994.6 ± 557.7 mg/day) was lower than those reported in other studies. It was reported that the intake of total polyphenols among subjects aged 60 years and above was 2770.7 ± 1552.4 mg/day ([@b24-06mjms26032019_oa3]). Additionally, a study reported that the intake of total polyphenols among 10,477 individuals aged 45 to 69 years of urban population in Poland was 1756.5 ± 695.8 mg/day ([@b25-06mjms26032019_oa3]). The study was conducted among the Western population, where fruit rich in polyphenols such as berries are highly accessible as compared in Malaysia. In addition, since the current study was conducted among individuals with low economic and education levels, the purchasing power of polyphenols-rich food could be hampered due to their background.

This study indicates that more women (26.3%) were identified as having somatic symptoms than men (14.9%). The situation is similar with another study where about 2.8% and 1.4% of women and men, respectively, were identified as having somatic symptoms ([@b26-06mjms26032019_oa3]). The much higher prevalence of symptoms of somatic symptoms in this study as compared to those reported in Silverstein ([@b26-06mjms26032019_oa3]) could be due to the different screening tools used in both studies. This study used GHQ as the screening tools and identified those with the symptoms, whilst the study by Silverstein ([@b26-06mjms26032019_oa3]) used data from National Comorbidity Survey involving adults from all age groups in the United States, with the clinical diagnosis of poor mental health.

The result shows that the prevalence of poor mental health (42.1%) according to total GHQ score is higher than those reported by several studies. The Malaysian National Health and Morbidity Survey (NHMS) reported that the prevalence of poor mental health for adults aged 45 to 59 years ranged from 24.9% to 27.7% ([@b27-06mjms26032019_oa3]), whilst a study conducted in Singapore had identified 16.6% of individuals with poor mental health according to total GHQ score ([@b28-06mjms26032019_oa3]). The high prevalence of poor mental health in this study could be due to most subjects in this study were recruited from low to middle income population. It was stated in NHMS that adults from low income families seems to be at risk of mental health problems ([@b27-06mjms26032019_oa3]). Individuals from socially and economically disadvantaged groups were more vulnerable to mental health problems ([@b29-06mjms26032019_oa3]).

In relation to cognitive status, the present study shows that women scored significantly higher than men in both immediate and delayed recalls of RAVLT. This is in contrast with the result by Lee at al. ([@b30-06mjms26032019_oa3]), where men showed better result in cognitive status as assessed by RAVLT scores. In another study by Teruya et al. ([@b31-06mjms26032019_oa3]), women scored better in the delayed recall category, but not in the immediate recall. In addition, a study by Sundermann et al. ([@b32-06mjms26032019_oa3]) showed that women outperformed men on verbal memory tasks throughout life. The gender difference in the cognitive functions may be related to the anatomical variations among both genders ([@b32-06mjms26032019_oa3]). There were significant gender and hippocampal volume/intracranial volume ratio (HpVR) interactions for immediate and delayed recall, determined using magnetic resonance imaging. It has been shown that the hippocampus regulates verbal memory ([@b33-06mjms26032019_oa3]). In addition, the volume of hippocampus is related to risk of amnestic mild cognitive impairment and Alzheimer's disease ([@b34-06mjms26032019_oa3]). RAVLT is also a sensitive indicator of global cognitive functioning, not merely verbal learning skills ([@b35-06mjms26032019_oa3]).

This study shows that intake of total flavonoids was significantly associated with anxiety and insomnia. A study which was conducted among elderly people residing in old-folks homes indicated that those who had more than 50% of wastage of vegetables, a main source of total flavonoids, were 3.91 times higher to develop insomnia ([@b36-06mjms26032019_oa3]). Subjects with insomnia were 19.55 times more likely to develop depression. One of the explanations of the association of flavonoids intake with anxiety and insomnia is the affinity of flavonoids for central benzodiazepine receptors ([@b37-06mjms26032019_oa3], [@b38-06mjms26032019_oa3]). Benzodiapines are tranquilisers which have been used in the treatment of anxiety and insomnia. Flavonoids from the medicinal herb *Scutellaria baicalensis* Georgi, have been shown to manifest an affinity for the benzodiazepine receptor comparable to that of the synthetic anxiolytic diazepam ([@b37-06mjms26032019_oa3]). Both studies have further underlined the potential of flavonoids in improving the treatment of anxiety. The significant association of total flavonoids intake with better anxiety and insomnia status may shed some light on the roles of polyphenols in protecting mental health during old age. Due to this, more studies to identify the related metabolic pathways of polyphenols in aging brain should be conducted.

Analysis of hierarchical binary logistic regression with education status, household income and energy intake as the control variables was carried out to determine the predictors of poor mental health and cognitive status among the subjects. The result indicates that fat intake was a predictor of somatic symptoms for both men (AOR = 1.04) and women (AOR=1.06). Somatic symptoms such as dizziness, headaches, insomnia and fatigue, are related to other mental health factors, such as anxiety and depression ([@b39-06mjms26032019_oa3]). Another study also used GHQ to measure symptoms of mental health, Western pattern comprised diet such as meat pies, processed meats, pizza, chips, hamburgers, white bread, sugar, flavoured milk drinks and beer was associated with a higher GHQ score after adjustments for age, socioeconomic status, education, and health behaviours. In contrast, traditional dietary pattern comprised mainly vegetables, fruit, beef, lamb, fish and whole-grain foods was found to be protective against major depression and anxiety disorders with lower odds ([@b40-06mjms26032019_oa3]). Inflammatory and oxidative processes are thought to be responsible for the occurrence and maintenance of depressive disorders. Mediterranean diet which was high in vegetables, fruits, legumes, whole grains, fish, olive oil and low-fat dairy products, is negatively associated with inflammatory markers. In contrast, Western diets which is high in refined carbohydrates and fats is associated with higher levels of C-reactive protein, a marker of low-grade inflammation ([@b40-06mjms26032019_oa3]).

Additionally, this study found that iron intake is protective against poor mental health as assessed by total GHQ score among women (AOR = 0.689). A study was conducted among iron deficient and iron replete women aged 18 to 50 years to investigate the effects of iron supplementation and high iron diet for 12 weeks on several health parameters using SF-36 ([@b41-06mjms26032019_oa3]). Mental health and vitality scores were lower in iron deficient than iron replete women at baseline. Both scores of mental health and vitality showed improvements during the intervention phase, however the increase in serum ferritin was higher in the supplementation group as compared to high iron diet group. The mechanism on how iron affects mental health is still unknown, however, iron plays important roles in the functioning of several neurotransmitters, namely dopamine, serotonin and catecholamines ([@b41-06mjms26032019_oa3]).

In addition, the result of this study shows that the intake of lignan was associated with better RAVLT immediate recall score among women (AOR = 1.071). Similar result was also seen in a study higher dietary intake of lignan was found to be associated with better cognitive performance as assessed using mini mental state examination (MMSE) for post-menopausal women ([@b42-06mjms26032019_oa3]). Intake of lignan was measured using a validated FFQ and the analysis was adjusted for duration of fertile life, dietary intakes of saturated fat, monounsaturated fat, polyunsaturated fat, fatty fish, energy-adjusted fibre intake, energy-adjusted alcohol intake, and serum levels of estradiol. Women who were 20 to 30 years of post-menopause were the most prominent in the better cognitive performance. Similarly, in another study, women aged 60 to 75 years with high lignan intake was associated with better cognitive ([@b43-06mjms26032019_oa3]). Among the cognitive performance that were positively associated with high lignan intake was processing capacity and speed, and in executive function ([@b43-06mjms26032019_oa3]). Among the mechanisms proposed for this association is the attenuation of deposits of amyloid β-peptide (Aβ). These deposits may lead to the formation of neuritic plaques, and neurofibrillary tangles in vulnerable brain regions. These depositions are among the key features of Alzheimer's disease ([@b44-06mjms26032019_oa3]).

Furthermore, this study shows that women with high cholesterol level were 3.14 times higher to have poor cognitive status as assessed by RAVLT delayed recall. The association of high cholesterol and cognitive was also studied by ([@b45-06mjms26032019_oa3]), where patients with and without familial hypercholecrolemia aged 50 years and above was recruited to determine the risk of mild cognitive impairment (MCI) in a population of patients with heterozygous familial hypercholesterolemia. Familial hypercholestemia is a condition involving LDL receptors dysfunction and is a life-long condition ([@b45-06mjms26032019_oa3]). There was a significant difference in the incidence of MCI between patients with (21.3%) and without (2.9%) familial hypercholesterolemia (*P* \< 0.01). Furthermore, patients with familial hypercholesterolemia showed significantly worse performance in several cognitive measures such as mini-mental state examination and verbal learning, independent of apoE4 or apoE2 status. The findings suggested that early exposure to elevated cholesterol or LDL receptors dysfunction may be risk factors for mild cognitive impairment ([@b45-06mjms26032019_oa3]).

Conclusion
==========

This study indicated that more than 40% of middle-aged adults from low to middle socioeconomic status in Kuala Lumpur had poor mental health according to total GHQ score. Additionally, more than half of the adults recruited in this study had poor cognitive status according to RAVLT immediate recall score. Fat intake was found to be associated with somatic symptoms for both genders. For women, iron intake protective against poor mental health, presented by total GHQ score. Additionally, intake of lignan and high cholesterol were found to be associated with RAVLT immediate and delayed recall, respectively, for women.

The high prevalence of poor mental health and cognitive in this population requires immediate attention by health professionals and policy-makers for advanced research and remedial actions. By identifying the risk factors of these problems, various clinical trials can be conducted among the middle-aged adults to maintain good mental health and quality of life throughout old age. For upcoming research, recruitment of subjects should cover wider geographical area and ethnic groups to elucidate the real situation of mental health and cognitive status among middle-aged adults in Malaysia.
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###### 

Subjects' demographics, socioeconomic and social profiles according to gender \[presented as number (%)\]

                                           Men (*n* = 121)   Women (*n* = 228)   All (*n* = 349)                
  ---------------------------------------- ----------------- ------------------- ----------------- ------ ----- ------
  **Marital status**                                                                                            
  Single                                   8                 6.6                 7                 3.1    15    4.3
  Married                                  108               89.3                180               78.9   288   82.5
  Divorced                                 3                 2.5                 13                5.7    16    4.6
  Widowed                                  2                 1.6                 28                12.3   30    8.6
  **Education status**                                                                                          
  No formal education                      2                 1.6                 13                5.7    15    4.3
  Primary education                        18                14.9                63                27.6   81    23.2
  Secondary education                      83                68.6                150               65.8   233   66.8
  Institute of higher learning             18                14.9                2                 0.9    20    5.7
  **Employment status**                                                                                         
  Not working                              7                 5.8                 121               53.1   128   36.7
  Working                                  86                71.1                17                7.4    103   29.5
  Retired                                  28                23.1                90                39.5   118   33.8
  **Living arrangements**                                                                                       
  Alone                                    5                 4.0                 4                 1.8    9     2.6
  With spouse                              2                 1.7                 20                8.8    22    6.3
  With children                            2                 1.7                 39                17.1   41    11.8
  With spouse and children                 104               86.0                145               63.6   249   71.3
  Others                                   8                 6.6                 20                8.7    28    8.0
  **Participation in social activities**                                                                        
  At least once a week                     25                20.6                59                25.8   84    24.1
  At least once a month                    18                14.9                69                30.3   87    24.9
  Less than once a month                   18                14.9                41                18.0   59    16.9
  No                                       60                49.6                59                25.9   119   34.1

###### 

Subjects' health behaviour according to gender \[presented as number (%)\]

                                             Men (*n* = 121)   Women (*n* = 228)   All (*n* = 349)                 
  ------------------------------------------ ----------------- ------------------- ----------------- ------- ----- ------
  **Participation in physical activities**                                                                         
  Everyday                                   14                11.6                24                10.5    38    10.9
  3--5 times per week                        8                 6.6                 11                4.8     19    5.4
  1--2 times per week                        27                22.3                35                15.4    62    17.8
  No                                         72                59.5                158               69.30   230   65.9
  **Smoking behaviour**                                                                                            
  Smoker                                     48                39.7                1                 0.4     49    14.0
  Former smoker                              25                20.6                0                 0.0     25    7.2
  Non-smoker                                 48                39.7                227               99.6    275   78.8
  **Intake of alcoholic beverages**                                                                                
  Drinker                                    25                20.7                1                 0.4     26    7.5
  Former drinker                             5                 4.1                 0                 0.0     5     1.4
  Non-drinker                                91                75.1                227               99.6    318   91.1
  **Intake of supplements**                                                                                        
  Fish oil                                   6                 5.0                 7                 3.1     13    3.7
  Multivitamins                              5                 4.1                 22                9.6     27    7.7
  Vitamin C                                  5                 4.1                 7                 3.1     12    3.4
  Calcium                                    3                 2.5                 9                 4.0     12    3.4
  Combination                                3                 2.5                 22                9.6     25    7.1
  Others                                     3                 2.5                 7                 3.1     10    2.9
  No                                         96                79.3                154               67.5    250   71.6

###### 

Energy and nutrients intake according to gender (presented as mean ± SD)

  Energy/Nutrients    Men (*n* = 121)   Women (*n* = 228)   *t*      95% CI           *P*
  ------------------- ----------------- ------------------- -------- ---------------- ------------------------------------------------------------
  Energy (kcal)       1933.3 ± 559.8    1586.3 ± 493.0      3.161    129.5--564.6     0.002[\*\*](#tfn2-06mjms26032019_oa3){ref-type="table-fn"}
  Protein (g)         71.6 ± 22.6       56.9 ± 22.2         3.061    5.2--24.2        0.003[\*\*](#tfn2-06mjms26032019_oa3){ref-type="table-fn"}
  Fat (g)             66.2 ± 24.2       51.7 ± 23.4         2.857    4.45--24.57      0.005[\*\*](#tfn2-06mjms26032019_oa3){ref-type="table-fn"}
  Carbohydrates (g)   262.6 ± 86.0      223.7 ± 68.9        2.458    7.54--70.24      0.016[\*](#tfn1-06mjms26032019_oa3){ref-type="table-fn"}
  Calcium (mg)        402.4 ± 259.5     327.9 ± 230.9       1.454    −27.05--176.08   0.149
  Iron (mg)           12.5 ± 6.0        12.1 ± 7.7          0.250    −2.72--3.51      0.803
  Sodium (mg)         1311.1 ± 778.6    966.8 ± 578.9       2.522    73.85--614.79    0.013[\*](#tfn1-06mjms26032019_oa3){ref-type="table-fn"}
  Potassium (mg)      1347.6 ± 412.3    1145.3 ± 500.1      1.962    −2.02--406.74    0.052
  Vitamin A (μg RE)   1040.6 ± 699.7    799.4 ± 586.6       1.818    −21.69--503.97   0.072
  Thiamine (mg)       0.6 ± 0.3         0.7 ± 0.3           −1.185   −0.21--0.05      0.239
  Riboflavin (mg)     1.0 ± 0.5         0.9 ± 0.6           0.387    −0.18--0.27      0.700
  Niacin (mg)         9.6 ± 3.0         7.6 ± 3.0           3.146    0.76--3.34       0.002[\*\*](#tfn2-06mjms26032019_oa3){ref-type="table-fn"}
  Folate (μg)         51.2 ± 39.6       54.9 ± 44.7         −0.392   −22.17--14.85    0.696
  Vitamin C (mg)      74.7 ± 48.8       115.6 ± 154.3       −1.400   −98.76--16.98    0.164
  Vitamin E (mg)      3.4 ± 2.2         4.0 ± 2.5           −0.99    −1.57--0.522     0.324

Significant at *P* \< 0.05, using independent student's *t*-test

Significant at *P* \< 0.00, using independent student's *t*-test

SD = standard deviation; CI = confidence interval

###### 

Subjects' total and individual polyphenols intake (presented as mean ± SD)

                               Men (*n* = 121)   Women (*n* = 228)   Total (*n* = 349)   *t*     *P*
  ---------------------------- ----------------- ------------------- ------------------- ------- ------
  **Phenolic acids (mg)**      452.7 ± 444.3     357.5 ± 393.0       382.9 ± 407.3       1.06    0.29
  **Total flavonoids (mg)**    310.7 ± 228.5     249.8 ± 192.4       265.4 ± 203.0       1.37    0.17
  **Anthocyanins (mg)**        3.77 ± 7.4        3.8 ± 7.3           3.8 ± 7.3           −0.01   0.99
  **Stillbenes (mg)**          0.1 ± 0.0         0.1 ± 0.1           0.1 ± 0.1           0.11    0.92
  **Lignan (mg)**              11.3 ± 15.4       8.0 ± 10.0          8.8 ± 11.6          1.18    0.24
  **Total polyphenols (mg)**   1131.8 ± 568.8    947.2 ± 549.5       994.6 ± 557.7       1.52    0.13

No significant difference using independent student's *t*-test

SD = standard deviation

###### 

Association of nutrients and polyphenols intake with mental health and cognitive functions \[presented as r\]

                           Somatic Symptoms                                            Anxiety & insomnia                                          Social dysfunction   Severe depression                                          Total GHQ                                                   RAVLT immediate recall                                      RAVLT delayed recall
  ------------------------ ----------------------------------------------------------- ----------------------------------------------------------- -------------------- ---------------------------------------------------------- ----------------------------------------------------------- ----------------------------------------------------------- -----------------------------------------------------------
  Energy (kcal)            −0.095                                                      −0.010                                                      0.005                −0.013                                                     −0.051                                                      0.165                                                       −0.066
  Protein (g)              −0.119                                                      −0.18                                                       −0.082               −0.070                                                     −0.142                                                      0.110                                                       −0.065
  Fat (g)                  −0.198[\*](#tfn6-06mjms26032019_oa3){ref-type="table-fn"}   −0.105                                                      −0.034               −0.048                                                     −0.159                                                      0.103                                                       −0.093
  Carbohydrates (g)        0.014                                                       0.093                                                       0.058                0.035                                                      0.071                                                       0.183                                                       −0.027
  Calcium (mg)             −0.109                                                      −0.027[\*](#tfn6-06mjms26032019_oa3){ref-type="table-fn"}   −0.081               −0.023                                                     −0.168                                                      0.010                                                       −0.067
  Iron (mg)                −0.138                                                      −0.190                                                      −0.124               −0.089                                                     −0.202[\*](#tfn6-06mjms26032019_oa3){ref-type="table-fn"}   0.071                                                       −0.174
  Sodium (mg)              0.008                                                       −0.043                                                      0.040                −0.021                                                     −0.012                                                      0.061                                                       −0.130
  Potassium (mg)           −0.164                                                      −0.103                                                      0.050                −0.062                                                     −0.127                                                      0.101                                                       −0.071
  Vitamin A (RE)           −0.093                                                      −0.110                                                      0.010                0.018                                                      −0.084                                                      −0.039                                                      −0.206[\*](#tfn6-06mjms26032019_oa3){ref-type="table-fn"}
  Thiamine (mg)            0.070                                                       0.042                                                       −0.058               −0.033                                                     0.028                                                       0.114                                                       0.042
  Riboflavin (mg)          −0.025                                                      −0.124                                                      −0.109               −0.049                                                     −0.107                                                      0.126                                                       −0.001
  Niacin (mg)              −0.174                                                      −0.127                                                      −0.062               −0.082                                                     −0.174                                                      0.177                                                       −0.042
  Folate (μg)              0.003                                                       −0.048                                                      −0.039               −0.053                                                     −0.044                                                      0.021                                                       −0.139
  Vitamin C (mg)           0.022                                                       −0.088                                                      0.102                −0.077                                                     0.051                                                       −0.003                                                      −0.035
  Vitamin E (mg)           0.021                                                       −0.061                                                      0.046                0.017                                                      −0.002                                                      0.015                                                       −0.110
  Phenolic acids (mg)      0.072                                                       0.227[\*](#tfn6-06mjms26032019_oa3){ref-type="table-fn"}    0.079                0.241[\*](#tfn6-06mjms26032019_oa3){ref-type="table-fn"}   0.225[\*](#tfn6-06mjms26032019_oa3){ref-type="table-fn"}    0.099                                                       −0.017
  Total flavonoids mg)     −0.222[\*](#tfn6-06mjms26032019_oa3){ref-type="table-fn"}   −0.190[\*](#tfn6-06mjms26032019_oa3){ref-type="table-fn"}   −0.066               −0.105                                                     −0.231[\*](#tfn6-06mjms26032019_oa3){ref-type="table-fn"}   −0.213[\*](#tfn6-06mjms26032019_oa3){ref-type="table-fn"}   −0.092
  Anthocyanins (mg)        0.415                                                       0.282                                                       −0.008               0.067                                                      0.344[\*](#tfn6-06mjms26032019_oa3){ref-type="table-fn"}    0.023                                                       0.073
  Stillbenes (mg)          0.655                                                       0.295                                                       0.343                0.052                                                      0.482                                                       −0.329                                                      −0.004
  Lignan (mg)              −0.086                                                      0.023                                                       −0.009               0.204                                                      0.028                                                       0.263[\*](#tfn6-06mjms26032019_oa3){ref-type="table-fn"}    0.056
  Total polyphenols (mg)   −0.067                                                      0.081                                                       0.023                0.155                                                      0.057                                                       0.015                                                       −0.062

Significant at *P* \< 0.05, using Pearson's correlation

###### 

Predictors of poor mental health and cognitive in men

                     Variable               Adjusted odds ratio (95%CI)   *R^2^*                                                     *P*
  ------------------ ---------------------- ----------------------------- ---------------------------------------------------------- -------
  Somatic symptoms   Step 1                                               0.040                                                      0.228
  Education status   0.536 (0.201--1.429)                                 0.213                                                      
  Household income   0.575 (0.218--1.516)                                 0.263                                                      
  Step 2                                    0.143                         0.048[\*](#tfn7-06mjms26032019_oa3){ref-type="table-fn"}   
  Energy             1.001 (0.999--1.003)                                 0.250                                                      
  Fat                1.041 (0.922--1.002)                                 0.048[\*](#tfn7-06mjms26032019_oa3){ref-type="table-fn"}   
  Total flavonoids   0.998 (0.995--1.000)                                 0.078                                                      

Significant at *P* \< 0.05, using hierarchical binary logistic regression. The control variables were education status, household income and energy intake.

There are no significant predictors for (i) anxiety & insomnia, (ii) total GHQ, (iii) RAVLT immediate recall and (iv) RAVLT delayed recall

###### 

Predictors of poor mental health and cognitive in women

                                       Variable               Adjusted odds ratio (95%CI)   *R^2^*                                                     *P*
  ------------------------------------ ---------------------- ----------------------------- ---------------------------------------------------------- ----------------------------------------------------------
  Somatic symptoms                     Step 1                                               0.026                                                      0.703
  Education status                     0.562 (0.184--1.717)                                 0.311                                                      
  Household income                     1.020 (0.333--3.127)                                 0.972                                                      
  Participation in social activities   0.769 (0.244--2.423)                                 0.654                                                      
  Step 2                                                      0.157                         0.052                                                      
  Energy                               1.002 (0.999--1.004)                                 0.145                                                      
  Fat                                  1.062 (0.893--1.007)                                 0.026[\*](#tfn9-06mjms26032019_oa3){ref-type="table-fn"}   
  Total flavonoids                     0.999 (0.996--1.002)                                 0.483                                                      
  Total GHQ                            Step 1                                               0.047                                                      0.524
  Education status                     1.057 (0.134--8.344)                                 0.958                                                      
  Household income                     1.298 (0.174--9.669)                                 0.799                                                      
  Step 2                                                      0.474                         0.013                                                      
  Energy                               1.002 (0.999--1.004)                                 0.182                                                      
  Iron                                 0.689 (0.479--0.991)                                 0.045[\*](#tfn9-06mjms26032019_oa3){ref-type="table-fn"}   
  Phenolic acids                       0.999 (0.994--1.003)                                 0.504                                                      
  Total flavonoids                     1.001 (0.997--1.005)                                 0.753                                                      
  Anthocyanins                         1.392 (0.836--2.317)                                 0.203                                                      
  RAVLT immediate recall               Step 1                                               0.130                                                      0.040[\*](#tfn9-06mjms26032019_oa3){ref-type="table-fn"}
  Education status                     0.219 (0.056--0.861)                                 0.030[\*](#tfn9-06mjms26032019_oa3){ref-type="table-fn"}   
  Household income                     2.230 (0.679--7.328)                                 0.186                                                      
  Step 2                                                      0.249                         0.090                                                      
  Energy                               1.000 (0.999--1.002)                                 0.544                                                      
  Total flavonoids                     1.000 (0.997--1.004)                                 0.808                                                      
  Lignan                               1.071 (1.007--1.139)                                 0.028[\*](#tfn9-06mjms26032019_oa3){ref-type="table-fn"}   
  RAVLT delayed recall                 Step 1                                               0.095                                                      0.050
  Education status                     0.322 (0.111--0.938)                                 0.038                                                      
  Household income                     2.017 (0.731--5.565)                                 0.176                                                      
  Step 2 (against poor score)                                 0.159                         0.038[\*](#tfn9-06mjms26032019_oa3){ref-type="table-fn"}   
  High cholesterol                     3.144 (1.032--9.615)                                 0.044[\*](#tfn9-06mjms26032019_oa3){ref-type="table-fn"}   
  Step 3                                                      0.172                         0.641                                                      
  Energy                               1.000 (0.998--1.001)                                 0.407                                                      
  Vitamin A                            1.000 (0.999--1.001)                                 0.951                                                      

Significant at *P* \< 0.05, using hierarchical binary logistic regression. The control variables were education status, household income and energy intake.

There are no significant predictors for (i) anxiety insomnia and
